SGOL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.181400E-01
Normal-vs-Stage2
5.996800E-01
Normal-vs-Stage3
4.725000E-01
Normal-vs-Stage4
7.332400E-01
Stage1-vs-Stage2
3.547400E-01
Stage1-vs-Stage3
2.988000E-01
Stage1-vs-Stage4
5.887800E-01
Stage2-vs-Stage3
1.551490E-04
Stage2-vs-Stage4
9.710000E-01
Stage3-vs-Stage4
1.848810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.702200E-01
Normal-vs-AfricanAmerican
8.244000E-01
Normal-vs-Asian
8.043800E-01
Caucasian-vs-AfricanAmerican
3.696000E-01
Caucasian-vs-Asian
6.703200E-01
AfricanAmerican-vs-Asian
4.359000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.054200E-01
Normal-vs-Female
6.852400E-01
Male-vs-Female
7.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.113800E-01
Normal-vs-Age(41-60Yrs)
6.177000E-01
Normal-vs-Age(61-80Yrs)
7.236000E-01
Normal-vs-Age(81-100Yrs)
8.248200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.059000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.731200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.894400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.735000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.644200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.888200E-01
Normal-vs-Daily Drinker
8.443600E-01
Normal-vs-Weekly Drinker
7.136400E-01
Normal-vs-Occasional Drinker
6.381200E-01
Normal-vs-Social Drinker
6.255000E-01
Non Drinker-vs-Daily Drinker
5.889800E-01
Non Drinker-vs-Weekly Drinker
7.721200E-01
Non Drinker-vs-Occasional Drinker
9.557800E-01
Non Drinker-vs-Social Drinker
6.832200E-01
Daily Drinker-vs-Weekly Drinker
5.656000E-01
Daily Drinker-vs-Occasional Drinker
6.109800E-01
Daily Drinker-vs-Social Drinker
4.084200E-01
Weekly Drinker-vs-Occasional Drinker
7.470000E-01
Weekly Drinker-vs-Social Drinker
9.954600E-01
Occasional Drinker-vs-Social Drinker
6.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.679000E-01
Normal-vs-Grade 2
6.240400E-01
Normal-vs-Grade 3
6.589200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.996000E-03
Grade 1-vs-Grade 3
2.800500E-04
Grade 1-vs-Grade 4
5.679000E-01
Grade 2-vs-Grade 3
9.118400E-02
Grade 2-vs-Grade 4
6.240400E-01
Grade 3-vs-Grade 4
6.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.512800E-01
Normal-vs-NonDiabetic
6.983000E-01
Diabetic-vs-NonDiabetic
5.631800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.631600E-01
Normal-vs-NoPancreatitis
7.489000E-01
Pancreatitis-vs-NoPancreatitis
7.482200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.458200E-01
Normal-vs-N1
6.364000E-01
N0-vs-N1
6.670800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.107200E-01
Normal-vs-TP53-NonMutant
7.620800E-01
TP53-Mutant-vs-TP53-NonMutant
6.22679999999765E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
